Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

Although type-in responses on surveys are limited and underestimate prevalence of use, such responses can help inform researchers when new compounds are used. Continued surveillance of use of new and uncommon drugs is needed to inform adequate public health response.